Desogestrel versus gestodene in oral contraceptives: influence on the clinical and histomorphological features of benign breast disease.

@article{Lieto1994DesogestrelVG,
  title={Desogestrel versus gestodene in oral contraceptives: influence on the clinical and histomorphological features of benign breast disease.},
  author={Andrea Di Lieto and Giuseppe De Rosa and Giovanni Albano and A M Pagnano and Marta Campanile and Luigi Maria Terracciano and Massimo Pontillo and E Cimmino and Andrea M. Covelli and Antonella Paladini},
  journal={European journal of obstetrics, gynecology, and reproductive biology},
  year={1994},
  volume={55 1},
  pages={71-83}
}
Forty-four female volunteers asking for oral contraception, affected by symptomatic benign breast disease (BBD) were evaluated to compare the effects on mastalgia and breast nodularity of two different low dose oral contraceptives (OCs), containing 20 micrograms [corrected] ethinylestradiol + 150 micrograms desogestrel (EE+D) and 30 micrograms ethinylestradiol + 75 micrograms gestodene (EE+G), respectively. Physical examination, bilateral thermography, X-ray and/or ultrasonography of breast… CONTINUE READING